aportes a la gestión necesaria para la sustentabilidad de la SALUD PÚBLICA como figura esencial de los servicios sociales básicos para la sociedad humana, para la familia y para la persona como individuo que participa de la vida ciudadana.
jueves, 6 de junio de 2024
Supreme Court judges wrestle with abortion access in emergency cases Sarah Owermohle By Sarah Owermohle April 24, 2024
https://www.statnews.com/2024/04/24/supreme-court-emergency-abortion-access/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-_CbWenvjLLdwL2IvwX4usO-mzmwLgKuKmEDzukWETC-m-2UR_Y7p5ng3khUC203-qh9PJA2E9T7olGgE7_qIX_AxU4ZA&_hsmi=310188054&utm_content=310188054&utm_source=hs_email
Regulating health care in real time
Two national health care meetings happened yesterday: one on MDMA-assisted therapy for PTSD, and another on abortion. My STAT colleagues have the stories to keep you (and me) up to date:
Questions asked, questions dodged: STAT’s Olivia Goldhill and Meghana Keshavan live-blogged an FDA advisory committee meeting on MDMA. Regulators discussed how they would manage risk in the treatment, and things got a little intense discussing race, sex, comorbidities, and more. This is the first new PTSD treatment to go up for review in 25 years — but at the end of the day, committee members voted overwhelmingly against the therapy. The agency will use the feedback to decide by Aug. 11 if it will get approval.
FDA advisory panel votes overwhelmingly against MDMA therapy for PTSD
Olivia Goldhill
Meghana Keshavan
By Olivia Goldhill and Meghana Keshavan June 4, 2024
https://www.statnews.com/2024/06/04/fda-advisory-panel-mdma-therapy-ptsd/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-88ARaP7WJ0-L6gE8QJzaMWLctticd_cUXBMoWaq4L-LVM3Zs9aqfCmxDYEsE3n7su-GRIrVcoE6cwMoWcV48pHf08dnQ&_hsmi=310188054&utm_content=310188054&utm_source=hs_email
Tussling over abortion policy: STAT’s Sarah Owermohle covered a Senate health committee hearing on reproductive health where representatives argued over the impact of restrictive abortion laws. The committee is not scheduled to look at any reproductive legislation right now, but the Supreme Court will likely release two decisions related to abortion this month: one on the medication mifepristone, and another on whether abortion can be considered emergency care.
Senators tussle over abortion policy against the backdrop of a presidential campaign
Sarah Owermohle
By Sarah Owermohle June 4, 2024
https://www.statnews.com/2024/06/04/abortion-senate-policy-campaign/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-971lPdqnq-tDFi9aIC1KNNkgykm2PGmJnX03im9PvDADIYdKDxy3MuFdZkRpGVFE9jlu0qfA-zE_9RVsUgc8CjS1PQkA&_hsmi=310188054&utm_content=310188054&utm_source=hs_email
Supreme Court mifepristone arguments focus on physicians’ right to sue, not FDA judgment
Sarah Owermohle
By Sarah Owermohle March 26, 2024
https://www.statnews.com/2024/03/26/supreme-court-mifepristone-arguments-fda/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-8yAmQSF0R3ikCETk995w1DkUibZNQyyk3Sz-GD5JG8TMlRqinb_M2HWRmw7Y3fFJ7VYrfAmHZxTjj1mgagmgqpRnSCyA&_hsmi=310188054&utm_content=310188054&utm_source=hs_email
No hay comentarios:
Publicar un comentario